Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression  by Shelton, Elaine L. & Yutzey, Katherine E.
02 (2007) 376–388
www.elsevier.com/locate/ydbioDevelopmental Biology 3Tbx20 regulation of endocardial cushion cell proliferation and
extracellular matrix gene expression
Elaine L. Shelton, Katherine E. Yutzey ⁎
Division of Molecular Cardiovascular Biology, Cincinnati Children’s Medical Center ML 7020, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
Received for publication 17 August 2006; revised 26 September 2006; accepted 27 September 2006
Available online 3 October 2006Abstract
While recent work has implicated Tbx20 in myocardial maturation and proliferation, the role of Tbx20 in heart valve development remains
relatively unknown. Tbx20 expression was manipulated in primary avian endocardial cells in order to elucidate its function in developing
endocardial cushions. Tbx20 gain of function was achieved with a Tbx20-adenovirus, and endogenous Tbx20 expression was inhibited with
Tbx20-specific siRNA in cultured endocardial cushion cells. With Tbx20 gain of function, the expression of chondroitin sulfate proteoglycans
(CSPG), including aggrecan and versican, was decreased, while the expression of the matrix metalloproteinases (MMP) mmp9 and mmp13 was
increased. Consistent results were observed with Tbx20 loss of function, where the expression of CSPG genes increased and MMP genes
decreased. In addition, cushion mesenchyme proliferation increased with infection of a Tbx20-adenovirus and decreased with transfection of
Tbx20-specfic siRNA. Furthermore, BMP2 treatment resulted in increased Tbx20 expression in endocardial cushion cells, and loss of Tbx20 led
to increased Tbx2 and decreased N-myc gene expression. Taken together, these data support a role for Tbx20 in repressing extracellular matrix
remodeling and promoting cell proliferation in mesenchymal valve precursor populations in endocardial cushions during embryonic development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Tbx20; Endocardial cushion development; Aggrecan; Versican; Mmp9; Mmp13; Cell proliferation; siRNA; ChickenIntroduction
Heart valve development is a complex process that is
essential to normal heart function. Congenital valve defects can
result in valve dysfunction (Rabkin-Aikawa et al., 2005) and
there is mounting evidence that early developmental defects in
valvulogenesis can lead to valve disease later in life (Cripe et al.,
2004; Garg et al., 2005). Much is known about the early events
in valve formation however, relatively little is known about how
primitive endocardial cushions remodel into mature valves. T-
box transcription factors function in various aspects of
cardiogenesis, including cardiac lineage determination, cham-
ber specification, epicardial development and specialization of
the conduction system (Plageman and Yutzey, 2005; Stennard
and Harvey, 2005). Tbx20 has been implicated in cardiac
muscle maturation and is expressed in developing heart valves
however, its specific role in valves and their precursor cell
populations has not been identified.⁎ Corresponding author. Fax: +1 513 636 5958.
E-mail address: Katherine.Yutzey@cchmc.org (K.E. Yutzey).
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doi:10.1016/j.ydbio.2006.09.047Recently, the role of Tbx20 in mammalian heart develop-
ment was investigated using targeted mutagenesis and RNAi
strategies in mice. In these studies, loss of Tbx20 function
resulted in decreased or delayed cardiac gene expression,
hypoplasia of the myocardium and decreased chamber matura-
tion (Cai et al., 2005; Singh et al., 2005; Stennard et al., 2005;
Takeuchi et al., 2005). In addition, a specific role for Tbx20 in
myocardial proliferation was proposed through increased N-
myc gene expression (Cai et al., 2005). In each case, mutant
mice lacking Tbx20 gene expression were embryonic lethal due
to failure of cardiac muscle maturation at approximately
embryonic day (E) 9, prior to valve development (Cai et al.,
2005; Stennard et al., 2005; Takeuchi et al., 2005). Further
evidence for Tbx20's role in heart muscle development comes
from loss of function studies in other animal model systems. In
zebrafish and Xenopus embryos, the loss of Tbx20 results in
heart looping and chamber maturation defects (Brown et al.,
2003; Stennard et al., 2003; Szeto et al., 2002). Taken together,
these studies have defined a role for Tbx20 in early cardiac
muscle development where it promotes primitive, proliferative
myocardium. Later in development, Tbx20 is expressed in the
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outflow tract (OFT) endocardial cushions and in the mitral and
tricuspid valves (Plageman and Yutzey, 2004; Stennard et al.,
2003; Yamagishi et al., 2004). While the loss of function studies
were very informative regarding Tbx20's role in regulating
myocardial proliferation and maturation, the role of Tbx20 in
valve development is still unclear.
Heart valvulogenesis is initiated in the AV canal and OFT by
signaling events originating in the myocardium that cause cells
in the endocardium to undergo an epithelial to mesenchymal
transformation (EMT) and migrate into the intervening cardiac
jelly. The result of EMT is the formation of endocardial
cushions composed of highly proliferative, undifferentiated,
mesenchymal valve progenitor cells embedded in an unorga-
nized extracellular matrix (ECM) (Armstrong and Bischoff,
2004; Hinton et al., 2006; Lincoln et al., 2006b; Person et al.,
2005; Schroeder et al., 2003). These cushions will ultimately
elongate and undergo ECM remodeling in order to form
functionally mature valves (Hinton et al., 2006; Lincoln et al.,
2004). One hallmark of the transition from endocardial cushion
to remodeling valve is a decrease in endocardial cushion cell
proliferation (Hinton et al., 2006; Lincoln et al., 2004). As
previously reported, murine endocardial cushion cells are
approximately 6 times more proliferative than cells in the
remodeling valve leaflet (Hinton et al., 2006) and decreased
proliferation is also a feature of valve remodeling in avian
embryos (Lincoln et al., 2004). In addition, valve remodeling is
characterized by increased organization and complexity of the
ECM. During endocardial cushion formation, proteoglycans are
diffusely and variably expressed throughout the cushion
(Hinton et al., 2006). However, beginning in the remodeling
stage of valve development and continuing into postnatal time
points, the ECM becomes stratified into three distinct layers: the
elastin-rich atrialis, the proteoglycan-rich spongiosa and the
collagen-rich fibrosa (Flanagan and Pandit, 2003; Hinton et al.,
2006; Lincoln et al., 2006b). While recent progress has been
made to describe this process histologically, the molecular
mechanisms governing this transition have not been elucidated.
The process by which endocardial cushions develop into
mature valve leaflets is marked by the expression of specific
ECM proteins and remodeling enzymes (Lincoln et al., 2006b).
Aggrecan (agg) and versican (vers) are major proteoglycan
constituents of the spongiosa layer in avian valves. Both are
large chondroitin sulfate proteoglycans (CSPG) that aggregate
with hyaluronan to form hydrated compressible ECM (Arci-
niegas et al., 2004; Luo et al., 2000). These CSPGs are not only
found in developing valves, but also in articular cartilage, where
they function to provide resistance against compressive forces
(Arciniegas et al., 2004; Pirok et al., 1997). The proper
distribution and organization of ECM in remodeling valves is
important for normal valve function (Hinton et al., 2006;
Rabkin et al., 2001) and is dependent on a coordinated
deposition and degradation of individual matrix proteins. As
in other tissues, matrix metalloproteinases (MMP) can mediate
the degradation and remodeling of ECM components in the
heart (Coker et al., 1998; Rabkin et al., 2001; Sternlicht and
Werb, 2001). Family members, including MMP9 (gelatinase B)and MMP13 (collagenase-3), are involved in the degradation
and reorganization of collagens, elastin and proteoglycans
(Passi et al., 1999; Rabkin-Aikawa et al., 2005; Sternlicht and
Werb, 2001). In addition, increased expression of MMP9 and
MMP13 was observed in diseased human mitral and aortic
valves with disorganized ECM (Rabkin et al., 2001; Soini et al.,
2001). Taken together, normal valve maturation requires
regulated ECM organization and remodeling however, the
mechanisms controlling this process are still unclear.
To investigate the role of Tbx20 in endocardial cushion
maturation and valve development, the expression of Tbx20,
CSPGs and MMPs in the endocardial cushions and remodeling
valves of avian embryos was examined. Tbx20 andMMP genes
are expressed at higher levels in endocardial cushions relative to
remodeling valves, while CSPG genes are expressed at higher
levels in remodeling valves relative to endocardial cushions. In
addition, a primary chicken endocardial cushion culture system
was used for Tbx20 gain and loss of function studies. The
effects of altered Tbx20 expression on CSPG and MMP gene
expression as well as the ability of Tbx20 to affect endocardial
cushion cell proliferation were examined. In these studies,
increased Tbx20 expression led to repression of CSPG genes
and increased expression of MMP genes, whereas the opposite
was observed with loss of Tbx20 function. Furthermore,
increased Tbx20 function led to increased proliferation in
endocardial cushion cells, while loss of Tbx20 led to decreased
proliferation. These findings coincide with high levels of Tbx20
promoting proliferation in endocardial cushions while lower
levels of Tbx20 in remodeling valves corresponds to decreased
rates of proliferation. Taken together, these studies are
consistent with a role for Tbx20 in antagonizing the transition
from endocardial cushion to remodeling valve.
Materials and methods
Chicken embryo collection
Fertilized white leghorn chicken eggs (CBT Farms, MD) were incubated at
38°C under high humidity. Embryos were collected at Hamburger Hamilton
(HH) stages 25, 26, 34 and 36, corresponding to embryonic days 4.5, 5, 8 and
10, respectively (Hamburger and Hamilton, 1951). For histology, hearts were
dissected in 1× phosphate-buffered saline (PBS) and fixed for 2 h in 4%
paraformaldehyde/PBS. After fixation, embryonic tissue was dehydrated in a
graded ethanol/PBS series (25%, 50%, 75%, 95% and 100%) and washed in
xylene before being embedded in paraplast (Sigma) for further processing. All
animal procedures were approved and performed in accordance with
institutional guidelines.
In situ hybridizations
The chicken Tbx20 sequence (GenBank accession number AB070544) was
amplified from HH stage 20 heart cDNA using previously reported degenerate
primers 5′-TGCTGRAAGTARTGRTG-3′ and 5′-GTGGAYAAYAAGAGATA-
3′ where R represents purine and Y represents pyrimidine (Iio et al., 2001;
Plageman and Yutzey, 2004). The chicken aggrecan sequence (GenBank
accession number U78555) was amplified from HH stage 34 wing cDNA using
the previously reported primers 5′-CTGCGTTCCCTGAGATTAC-3′ and 5′-
TTGCCAGGTCGATCTCAC-3′ (Li et al., 1996; Lincoln et al., 2006a). The
chicken versican sequence (GenBank accession number NM_204787) was
amplified from HH stage 36 wing cDNA using the primers 5′-CAAGGCGCT-
GAGTGCTAAATG-3′ and 5′-AGGGGCTAATACTGCTCTGG-3′ (Shinomura
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AF222690) was amplified from HH stage 30 heart cDNA using the primers 5′-
GCTGCCACTTCCCCTTCATCTTTG-3′ and 5′-CGGGGGCCCA-
CTGCGTTCTTG-3′ (Hahn-Dantona et al., 2000). The chicken mmp13
sequence (GenBank accession number AF070478) was amplified from HH
stage 30 cardiac outflow tract cDNA using the primers 5′-TGATGCCATAA-
CAAAACTTCGTG-3′ and 5′-AGATGCTAGATTGCTGGGACTTA-3′ (Lei et
al., 1999). All sequences were amplified by reverse transcriptase polymerase
chain reaction (RT-PCR), subcloned into pGEM T-vector (Promega) and
confirmed by sequencing. For each sequence, antisense RNA probes were
generated as previously reported (Ehrman and Yutzey, 1999) with the following
modifications. The Tbx20 probe was synthesized with T3 polymerase from a
plasmid linearized with XhoI. The aggrecan and mmp13 probes were
synthesized with Sp6 polymerase from plasmids linearized with NcoI. The
versican and mmp9 probes were synthesized using T7 polymerase from
plasmids linearized with NotI.
In situ hybridization of tissue sections was performed as previously
described (Somi et al., 2004) with the following modifications. Paraformalde-
hyde-fixed chicken hearts were embedded in paraffin, and 14 μm sections were
cut and mounted onto Superfrost Plus microscope slides (Fisher Scientific).
Sections were then deparaffinized in xylene, rehydrated through an ethanol/
distilled water series (100%, 95%, 75% and 50%) and then rinsed in 1× PBS.
Sections were treated with 20 μg/ml proteinase K/PBS for 6 min at 37°C.
Hybridizations using 170 μl of 0.5 μg/ml DIG-labeled riboprobe were carried
out in Coverwell Incubation Chambers (Grace Biolabs). Color reactions using
nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP;
Roche) were allowed to develop from 3 to 48 h. Slides were then rinsed in 1×
PBS/0.1% Tween 20, dehydrated in a graded ethanol series, rinsed in xylene and
coverslipped using Cytoseal (Electron Microscopy Sciences).
Endocardial cushion cell culture
Embryonic chicken hearts were collected at HH stage 25, and pre-fused
endocardial cushions were dissected using tungsten needles. Cushion cells free
of myocardial contamination were cultured as previously reported (Lincoln et
al., 2006a) with the following modifications. Dissected cushions from 12
embryos were plated onto a 0.01% collagen coated two-well chamber slide
(Labtek) with 1 ml media (10% fetal bovine serum, 1% penicillin/streptomycin,
1× M199 (Invitrogen)). Endocardial cushion cultures were incubated for a total
of 4 days. In some cases, recombinant human BMP2 or recombinant human
Noggin (R&D Systems) was added to the culture media, with a final
concentration of 200 ng/ml at the time of plating and replenishment after
48 h. Cells were collected after 4 days in culture for RNA isolation or fixed in
4% paraformaldehyde/PBS for immunohistochemistry.
Recombinant adenovirus
A recombinant adenovirus containing the full length coding region of
murine Tbx20 (AdTbx20) was generated from a pAC-CMV-Tbx20 expression
plasmid (Plageman and Yutzey, 2004) using previously described methods
(Gomez-Foix et al., 1992). For Tbx20 gain of function studies, endocardial
cushion cells cultured for 24 h were infected with 108 plaque forming units of the
AdTbx20 virus or a β-galactosidase (Adβ-gal) control virus in serum free media
(1× M199 (Invitrogen)). Cells were incubated with the infection media for 6 h,
which was then replaced with new supplemented culture media. After 48 h,
RNA was isolated or cells were fixed in 4% paraformaldehyde/PBS for
immunohistochemistry. Infection efficiency was determined to be greater than
90% in Adβ-gal-infected cultures as measured by staining with 1 mg/ml X-gal
(Amresco) using previously a reported method (Liberatore et al., 2002). High
expression of the murine Tbx20 viral transcript was confirmed using RT-PCR
and ectopic Tbx20 protein expression was confirmed by immunohistochemistry
with a rabbit polyclonal antibody directed against Tbx20 (Orbigen).
Tbx20 siRNA
A 19 nucleotide RNA duplex corresponding to the chicken Tbx20 sequence
(GenBank accession numberAB070544) was designed using BLOCK-iT™RNAi Designer (Invitrogen). The Tbx20 siRNA with sequence 5′-GCA-
UCCAUUGCUACACCUAdTdT-3′ and 5′-UAGGUGUAGCAAU-
GGAUGCdTdT-3′ and a scrambled control siRNA with sequence
5′-CCGGUAAUGACACCCAAUUdTdT-3′ and 5′-AAUUGGGUGU-
CAUUACCGGdTdT-3′ were obtained from Invitrogen. A final siRNA
concentration of 100 nM was used with Lipofectamine 2000 (Invitrogen) to
transfect cultured endocardial cushion cells as described by the manufacture's
protocol. Transfected cells were incubated 48 h before RNA isolation or fixation
for immunohistochemistry. The transfection efficiency was determined by co-
transfection of the FITC-labeled (λex=494 nm) BLOCK-iT™ Fluorescent
Oligo (Invitrogen) along with siRNA oligos. Co-transfected cells were cultured
and fixed in 4% paraformaldehyde/PBS for 15 min and then counterstained with
a 1:1000 dilution of TO-PRO-3 iodide (λex=642) (Molecular Probes) in 1×
PBS. Fluorescence was detected using a Nikon PCM 2000 confocal microscope
and images were obtained using Simple PCI software. The percent of positively
transfected cells was calculated by dividing the number of FITC/TO-PRO-3
iodide double-labeled nuclei by the number of total TO-PRO-3 iodide-labeled
nuclei per microscopic field. In three independent experiments, a total of 10
fields containing at least 75 cells per field were counted for each treatment
group. The level of Tbx20 mRNA expression was determined using real-time
RT-PCR, and Tbx20 protein expression was detected by immunohistochemistry
on Tbx20 siRNA and scrambled control transfected cultures using a rabbit
polyclonal antibody directed against Tbx20 (Orbigen).
Immunohistochemistry
Endocardial cushion cell cultures were fixed with 4% paraformaldehyde/
PBS for 30 min, washed three times in PBS/0.1%Tween 20 and treated with 3%
hydrogen peroxide/PBS for 30 min. Immunohistochemistry was performed
using an ABC peroxidase staining kit (Pierce) according to the manufacture's
protocol. A rabbit polyclonal antibody directed against Tbx20 (Orbigen) was
used at a 1:200 dilution in blocking solution. Mouse monoclonal antibodies
directed against aggrecan (Abcam) and versican (Developmental Studies
Hybridoma Bank) were used at a 1:200 dilution in blocking solution. All
primary antibodies were incubated overnight at 4°C. Detection of antibody
reactivity was visualized using DAB substrate (Pierce).
BrdU incorporation and quantification
BrdU-positive nuclei were identified via immunohistochemistry using a
BrdU detection kit (Zymed). BrdU labeling reagent (Zymed) was diluted
1:100 in culture media and incubated with endocardial cushion cell cultures
for 1.5 h prior to fixation with cold 70% ethanol for 15 min at 4°C. Cells
were treated with 3% hydrogen peroxide/methanol for 10 min, washed three
times with 1× PBS and incubated in blocking solution for 10 min. A
biotinylated mouse anti-BrdU primary antibody was used followed by a
streptavadin–peroxidase-conjugated secondary antibody. A colorimetric reac-
tion was carried out using DAB, followed by counterstaining with
hematoxylin. The percent of proliferating cells was calculated by dividing
the number of BrdU-labeled nuclei by the number of total nuclei per
microscopic field. In three independent experiments, a total of 10 fields
containing at least 75 cells per field were counted for each treatment group.
Statistical significance of observed differences was determined by Student's
t-test.
RT-PCR analysis of gene expression
Total RNA was isolated from cultures of 12 endocardial cushions per
experimental group using 200 μl Trizol reagent (Invitrogen) and cDNA was
generated from the entire RNA sample from each group using SuperScript II
(Invitrogen), as described by the manufacture's protocol. Total RNA was also
isolated from 6 chicken AV canals at HH stages 25 and 36 using 800 μl Trizol
reagent and cDNA was generated from 5 μg of each RNA sample using
SuperScript II, as described by the manufacture's protocol. 1 μl cDNAwas used
for analysis by semi-quantitative RT-PCR or quantitative real-time RT-PCR (MJ
Research Opticon 2). RT-PCR reactions were performed at 35 cycles using
20 pmol of the following primers: Tbx20 5′-CAGGCAACGCAAAGCAGAG-3′
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ACCTCTTTGC-3′ and 5′-TGGGGAGGAGGGCAACAT-3′, versican 5′-
CCTCACTGGTAAGCCCACAT-3′ and 5′-TGATTCTTCTTGGCCCATTC-3′,
mmp9 5′-GCCACTTCCCCTTCATCT-3′ and 5′-GTTGCCACCATTGGTGTA-
3′, mmp13 5′-TGATGCCATAACAAAACTTCGTG-3′ and 5′-AGATGCTA-
GATTGCTGGGACTTA-3′, N-myc 5′-ACCACTTTTCCATCGGTCAG-3′ and
5′-TTGGTTGGATCATGGGTTTT-3′, Tbx2 5′-AACACGGCTTTACCATCC-
TG-3′ and 5′-TTCAGCTGCGTGATCTTGTC-3′, β-actin 5′-ATCACA-
GGGGTGTGGGTGTT-3′ and 5′-AATGAGAGGTTCAGGTGCCC-3′. Gene
expression levels determined by quantitative real-time RT-PCR were calculated
as previously reported (Lincoln et al., 2006a) with the following modifications.
A standard curve was generated for each primer set using HH stage 34 whole
heart cDNA and all values were normalized to GAPDH expression. Consistent
GAPDH expression in all experimental groups was confirmed by normalizing
GAPDH values to β-actin expression. Real-time RT-PCR results represent at
least three independent experiments (n=3–6) with reactions performed in
duplicate. For developmental studies, expression is represented as arbitrary units
of fluorescence intensity for data generated with equivalent RNA input and
normalized to GAPDH. For endocardial cushion cultures, expression was
calculated as fold increase or percent decrease determined by dividing the
experimental value by the control value. The control value was then set to 1% or
100%, respectively. Statistical significance of observed differences was
determined by Student's t-test.Results
CSPG and MMP genes are differentially expressed in
endocardial cushions and remodeling valves
Tbx20 is expressed in chicken and mouse endocardial
cushions and in the remodeling valves (Plageman and Yutzey,
2004; Stennard et al., 2003; Yamagishi et al., 2004). In
addition, CSPG genes, including aggrecan and versican, and
MMP genes, including MMP9 and MMP13, are expressed in
mature and diseased valves. In situ hybridizations were
performed on sectioned embryonic chicken hearts in order to
localize the expression of aggrecan (agg), versican (vers),
mmp9 and mmp13 in relation to Tbx20 during the stages of
endocardial cushion formation (HH stage 25) and valve
remodeling (HH stage 34) in vivo. At HH stage 25, Tbx20 is
expressed at high levels throughout the entire AV endocardial
cushion (Fig. 1A). In contrast, agg expression is restricted to
the subatrial region (arrow) of the endocardial cushion and is
excluded from the core (star) of the cushion (Fig. 1C). vers is
also expressed in the subatrial region of the endocardial
cushion and excluded from the core region (Fig. 1E). In
contrast, mmp9 is expressed throughout the entire cushion
including the subatrial and core regions, and expression was
also observed in the subepicardial space (open arrowhead) at
this stage (Fig. 1G). Similarly, mmp13 is expressed through-
out the subatrial and core regions of the endocardial cushion
at HH stage 25 (Fig. 1I).
In HH stage 34 remodeling valves, Tbx20 is expressed at
more diffuse levels in the leaflets (arrowhead) and tips
(asterisks) of the remodeling mitral valve (Fig. 1B). In contrast,
agg becomes highly expressed throughout the valve leaflet but
is expressed at lower levels at the most distal tips (Fig. 1D). vers
is also expressed throughout the remodeling valve but is
predominant at the distal tips of the valve leaflets (Fig. 1F). By
HH stage 34, mmp9 is expressed at low levels in the remodelingmitral valve, with expression being concentrated at the atrial
aspect of the valve leaflet and the distal tips (Fig. 1H), while
mmp13 is expressed at low levels in the ventricular aspect of
the valve leaflet and at the distal tips (Fig. 1J). Similar
expression of Tbx20, agg, vers, mmp9 and mmp13 was found
in the remodeling tricuspid valve leaflets with the exception of
the muscular portion of the mural leaflet (data not shown).
Together these expression studies show that Tbx20, mmp9 and
mmp13 are expressed throughout the core of the endocardial
cushion, while the expression of agg and vers is restricted to the
subatrial region. Later in remodeling valves, the expression of
agg and vers is expanded throughout the valve leaflet, while
Tbx20, mmp9 and mmp13 expression is more diffuse and
compartmentalized compared to the expression in endocardial
cushions.
Tbx20, CSPG and MMP expression was further quantified
using RNA isolated from AV canals of HH stage 25 and HH
stage 36 chicken embryos. The expression levels of Tbx20,
agg, vers, mmp9 and mmp13 were measured using quantitative
real-time RT-PCR (Fig. 2). At HH stage 25 (endocardial cushion
stage), the expression of Tbx20 is approximately 1.5-fold higher
than later at HH stage 36 (valve remodeling stage). Similarly,
the expression of mmp9 and mmp13 is more than 2-fold higher
at HH stage 25 than later at HH stage 36. In contrast, the
expression of agg and vers is more than 4-fold higher in
remodeling valves (HH stage 36) than in endocardial cushions
(HH stage 25). These results indicate that the expression of
Tbx20, mmp9 and mmp13 is relatively higher in endocardial
cushions than in remodeling valves. In contrast, expression of
agg and vers is increased in remodeling valves relative to
undifferentiated endocardial cushions.
Tbx20 gain of function results in decreased CSPG expression
and increased MMP expression in cultured endocardial
cushion cells
The ability of Tbx20 to affect CSPG and MMP expression in
undifferentiated endocardial cushions was examined. Primary
cultures derived from unfused endocardial cushions removed
from the AV canals of HH stage 25 chicken embryos were
infected with an adenovirus that expresses murine Tbx20
(AdTbx20) or a control adenovirus that expresses β-gal (Adβ-
gal). Endocardial cushion cells were infected with greater than
90% efficiency, as determined by X-gal staining of Adβ-gal-
infected cultures (data not shown). High levels of expression of
the Tbx20 viral transcript were determined by real-time RT-
PCR and increased Tbx20 protein was detectable by immuno-
histochemistry (data not shown). The effect of increased Tbx20
on the expression of CSPG genes was determined by real-time
RT-PCR. Endocardial cushion cultures infected with AdTbx20
had an approximately 60% reduction in agg (Fig. 3E) and vers
(Fig. 3F) mRNA levels relative to Adβ-gal-infected controls.
This reduction was confirmed by immunohistochemistry using
antibodies specifically directed against Agg and Vers. Expres-
sion of Agg and Vers protein was apparent in cells infected
with Adβ-gal (Figs. 3A, C), but not in cells infected with
AdTbx20 (Figs. 3B, D). In addition, the expression of mmp9
Fig. 1. CSPG and MMP genes are differentially expressed in endocardial cushions and remodeling valves. Expression of Tbx20, aggrecan, versican, mmp9 and
mmp13 was examined in sectioned HH stage 25 and HH stage 34 chicken hearts. In situ hybridizations show Tbx20 (A), mmp9 (G) and mmp13 (I) are expressed
throughout the entire AVendocardial cushion including the subatrial region (arrow) and cushion core (star). In addition, expression of mmp9 was also detected in the
subepicardial space (open arrowhead in panel G). In contrast, aggrecan (C) and versican (E) are expressed only in the subatrial region of the cushion (arrows). In
remodeling mitral valves, Tbx20 (B) is expressed in the valve leaflet (arrowhead) and distal tips (asterisk). At HH stage 34, aggrecan (D) is expressed at high levels in
the valve leaflet, but is excluded from the distal tips, while versican (F) is expressed throughout the leaflet, with increased expression at the distal tips. In remodeling
valves, mmp9 (H) is expressed throughout the leaflet with concentrated expression in the atrial aspect of the leaflet and in the distal tips, while mmp13 (J) is expressed
in the ventricular aspect of the leaflet and in the distal tips. EC, endocardial cushion; MV, mitral valve.
380 E.L. Shelton, K.E. Yutzey / Developmental Biology 302 (2007) 376–388
381E.L. Shelton, K.E. Yutzey / Developmental Biology 302 (2007) 376–388and mmp13 mRNAwas measured by real-time RT-PCR in cells
infected with Adβ-gal or AdTbx20. In cells infected with
AdTbx20, the expression of mmp9 was increased 3-fold (Fig.
3G), and the expression of mmp13 was increased 5.5-fold (Fig.
3H). These studies demonstrate that Tbx20 gain of function
results in decreased agg and vers expression and increased
mmp9 and mmp13 expression in endocardial cushion cell
cultures.
Tbx20 loss of function results in increased CSPG expression
and decreased MMP expression
In order to achieve endogenous Tbx20 loss of function, a
Tbx20-specific siRNA was transfected into primary chicken
endocardial cushion cells. Scrambled control siRNA was also
transfected in parallel experiments. To determine the efficiency
of transfection, a fluorescently labeled oligonucleotide was co-
transfected with the siRNA and cells were counterstained with
TO-PRO-3 iodide to visualize the nuclei (Figs. 4A, C, E).
Primary endocardial cushion cells were transfected with greater
than 70% efficiency in the presence or absence of co-transfected
siRNA (Fig. 4G). Knockdown of Tbx20 protein expression was
evident using immunohistochemistry with a Tbx20-specific
antibody (Figs. 4B, D, F). Cells transfected with Tbx20-specific
siRNA had significantly reduced Tbx20 expression in the
nucleus (Fig. 4B) relative to scrambled siRNA (Fig. 4D) or
untransfected controls (Fig. 4F). In addition, transfection with
Tbx20-specific siRNA resulted in an approximately 85%
reduction of Tbx20 mRNA levels (Fig. 4H) as determined by
real-time RT-PCR. There was no detectable change in Tbx20Fig. 2. Differential expression of Tbx20, CSPG and MMP genes during
endocardial cushion and remodeling valve stages. Expression of Tbx20, aggre-
can, versican, mmp9 and mmp13 was examined in isolated AV canals from HH
stage 25 or HH stage 36 chicken embryos using real-time RT-PCR. The
expression of Tbx20,mmp9 andmmp13was decreased at HH stage 36 compared
to the expression at HH stage 25. In contrast the expression of aggrecan and
versican at HH, stage 36 was increased compared to the expression at HH
stage 25. Values on the y-axis represent arbitrary units of fluorescence intensity
for data obtained with equivalent RNA input normalized to GAPDH. These data
are representative of 3 independent real-time RT-PCR experiments performed in
duplicate (n=3). Statistical significance of observed differences between gene
expression levels at HH stage 25 and HH stage 36 is indicated by an asterisk
(P<0.05) and error bars represent standard error of the mean.gene expression following transfection of the scrambled siRNA
control (Fig. 4H). These data indicate that primary chicken
endocardial cushion cells can be efficiently transfected with
sequence-specific siRNA in order to produce a significant loss
of Tbx20 function.
The regulatory effects of Tbx20 knockdown on CSPG and
MMP expression were examined in primary endocardial
cushion cells removed from HH stage 25 AV canals. In cells
transfected with Tbx20-specific siRNA, agg expression
increased approximately 4-fold (Fig. 5A) and vers expression
increased approximately 6-fold (Fig. 5B). In contrast, mmp9
expression decreased approximately 80% (Fig. 5C) and
mmp13 expression decreased approximately 50% (Fig. 5D)
as measured by real-time RT-PCR. Taken together, loss of
Tbx20 function leads to increased expression of CSPG genes
and decreased expression of MMP genes. These results from
loss of Tbx20 function are consistent with the adenoviral gain
of Tbx20 function data and support a role for Tbx20 in
repressing CSPG expression and promoting MMP expression
in primitive endocardial cushion cells.
Tbx20 promotes endocardial cushion cell proliferation
Heart valve development is characterized by high prolifera-
tion in endocardial cushions and decreased proliferation in
remodeling valves (Hinton et al., 2006; Lincoln et al., 2004).
Targeted mutagenesis of Tbx20 in mice suggests Tbx20
promotes myocardial cell proliferation in the primitive heart
tube (Cai et al., 2005). To determine if Tbx20 has a similar role
in endocardial cushion cells, Tbx20 gain and loss of function
studies were performed and cell proliferation was assessed.
Endocardial cushion cultures were infected with AdTbx20 or
Adβ-gal for gain of function studies or transfected with Tbx20-
specific siRNA or scrambled control siRNA for loss of function
studies. The number of cells in S-phase of the cell cycle was
measured by BrdU incorporation and used as an indication of
proliferation. A proliferation index was determined by dividing
the number of BrdU-labeled nuclei by the number of total nuclei
per microscopic field. The normal proliferation index of
endocardial cushion cells infected with Adβ-gal (Fig. 6A) or
transfected with scrambled siRNA (Fig. 6C) was approximately
20% (Fig. 6E). Cells that were infected with AdTbx20 (Fig. 6B)
were significantly more proliferative, with a proliferation index
of over 40% (Fig. 6E). In contrast, cells transfected with Tbx20-
specific siRNA (Fig. 6D) were significantly less proliferative,
with a proliferation index of less than 10% (Fig. 6E). These data
are consistent with a role for Tbx20 in promoting proliferation
in endocardial cushions.
BMP2 induces Tbx20 and altered Tbx20 function affects the
expression of Tbx2 and N-myc in endocardial cushion cells
BMP2 induces Tbx20 expression in cardiac primordia prior
to cardiomyogenic differentiation and its expression in AV
canal myocardium is required for endocardial cushion forma-
tion (Ma et al., 2005; Plageman and Yutzey, 2004; Rivera-
Feliciano and Tabin, 2006). The ability of BMP2 to induce
Fig. 3. Tbx20 gain of function results in decreased expression of CSPGs and increased expression of MMPs. Adenoviruses expressing β-gal (Adβ-gal) or Tbx20
(AdTbx20) were used to infect primary avian HH stage 25 endocardial cushion cells. Immunohistochemistry with antibodies specific for aggrecan (A, B) or versican
(C, D) was used to measure aggrecan and versican protein levels following infection. Cells infected with AdTbx20 had less immunoreactivity (B, D, arrows indicate
lack of staining) than cells infected with Adβ-gal (A, C, arrows indicate staining). These results were confirmed by real-time RT-PCR. Cells infected with AdTbx20
had reduced expression of aggrecan (E) and versican (F) (n=6, P<0.01). The expression of mmp9 and mmp13 was also measured in infected cells using real-time
RT-PCR. In cells infected with AdTbx20, mmp9 (G) and mmp13 (H) expression was increased relative to expression in cells infected with Adβ-gal (n=6, P<0.05).
Fold changes were determined by dividing experimental values by control values with control values set to 1. Asterisks indicate statistically significant differences
from control values and error bars represent standard error of the mean.
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gated. AV endocardial cushions were removed from the
surrounding myocardium of HH stage 25 chicken embryos
and cultured with or without the addition of recombinant humanBMP2 or Noggin, a BMP inhibitor. RNA was isolated and
Tbx20 expression levels were measured using real-time RT-
PCR. Addition of BMP2 induced Tbx20 expression while
addition of Noggin repressed endogenous Tbx20 expression
Fig. 4. Tbx20-specific siRNA transfected into primary chicken endocardial cushion cells results in decreased Tbx20 mRNA and protein expression. (A, C, E) Primary
chicken endocardial cushion cells were co-transfected with siRNA and FITC-labeled fluorescent oligos (green) to visualize transfection efficiency. Cells were
counterstained with TO-PRO-3 iodide (blue) to visualize the nuclei. Examples of positively transfected cells are indicated by white arrows. Transfection efficiency was
determined as the number of cells with incorporation of FITC-labeled oligonucleotide/total TO-PRO-3-positive nuclei (G). These analyses demonstrated that cultures
were consistently transfected at 70–80% efficiency. (B, D, F) Tbx20 protein expression was examined by immunohistochemistry with an antibody specific for Tbx20
in parallel cultures of siRNA-transfected cells. Cells transfected with Tbx20-specific siRNA (B) had significantly reduced nuclear staining (arrows indicate cells with
reduced Tbx20 immunoreactivity) compared to controls (D, F, arrows indicate Tbx20 immunopositive cells). In Tbx20-specific siRNA transfected cultures (B), a
subset of cells remained Tbx20 immunopositive (arrowheads). Tbx20 mRNA expression was quantified using real-time RT-PCR (H). Cells transfected with Tbx20-
specific siRNA had an 80% reduction in Tbx20 mRNA relative to untransfected and scrambled siRNA controls. Asterisks indicate statistically significant differences
from control values and error bars represent standard error of the mean (n=3, P<0.01).
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demonstrate that BMP2 can induce Tbx20 in endocardial
cushion cells and that inhibition of endogenous BMP signaling
by Noggin decreases Tbx20 gene expression levels. Bmp2 is
required for endocardial cushion formation (Ma et al., 2005;
Rivera-Feliciano and Tabin, 2006; Sugi et al., 2004), and the
ability of BMP2 to induce Tbx20 in endocardial cushion cells isconsistent with Tbx20 regulation by BMP signaling in the early
stages of endocardial cushion development.
It was previously reported that Tbx20 affects myocardial
proliferation by directly repressing Tbx2, and thus relieving the
direct repression of Tbx2 onN-myc expression (Cai et al., 2005).
To determine if a similar mechanism occurs in endocardial
cushion cells, cultured cells were transfected with Tbx20-
Fig. 5. Tbx20 loss of function results in increased CSPG expression and decreased MMP expression. Primary endocardial cushion cells were transfected with Tbx20-
specific or scrambled control siRNA. Cells transfected with Tbx20-specific siRNA had increased expression of aggrecan (A) and versican (B) and decreased
expression of mmp9 (C) and mmp13 (D), relative to untransfected and scrambled siRNA controls as measured by real-time RT-PCR. Asterisks indicate statistically
significant differences from control values and error bars represent standard error of the mean (n=4, P<0.05).
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and N-myc mRNA levels were measured by real-time RT-PCR.
In cells transfected with Tbx20-specific siRNA, Tbx2 expression
increased by approximately 2-fold (Fig. 7B), while N-myc
expression decreased by approximately 60% (Fig. 7C). These
studies provide evidence that Tbx20 similarly regulates
endocardial cushion and myocardial cell proliferation through
Tbx2 and N-myc gene expression. Taken together, these results
are consistent with a role for Tbx20 in maintaining the endo-
cardial cushions as primitive, undifferentiated and proliferative.
Discussion
Gain and loss of function strategies were used to examine the
role of Tbx20 in developing avian endocardial cushions. During
normal valve development, Tbx20, mmp9 and mmp13 are
expressed at higher levels in endocardial cushions relative to
remodeling valves, while agg and vers are expressed at higher
levels in remodeling valves relative to endocardial cushions.
Additionally, endocardial cushion cells are more proliferative
than cells in remodeling valves (Hinton et al., 2006). In these
experiments, increased Tbx20 leads to decreased CSPG
expression and increased MMP expression whereas the
opposite trend occurs with loss of Tbx20. Furthermore,
increased Tbx20 induces cell proliferation in endocardial
cushion cultures, while proliferation decreases with loss of
Tbx20. These results are consistent with Tbx20 expression in
highly proliferative, unremodeled valve precursors and suggest
that Tbx20 functions to maintain valve precursors in an
immature, highly proliferative state, as has also been notedfor Tbx20 function in primitive myocardium. Taken together, a
model for the functions of Tbx20 in valve development (Fig. 8)
can be generated in which high levels of Tbx20 early in cushion
mesenchyme maintain primitive, proliferative, unremodeled,
endocardial cushions, while lower levels of Tbx20 later in
development occur in more highly differentiated, less prolif-
erative, remodeling valves.
Increased Tbx20 expression promotes proliferation in
endocardial cushion cells. In this report and in a previously
published study, altered Tbx20 function affects the expression
of N-myc and Tbx2 (Cai et al., 2005). In studies of primitive
mouse myocardium lacking Tbx20, it was suggested that Tbx20
acts to increase N-myc expression by repressing Tbx2, a
transcriptional repressor (Cai et al., 2005). However, it is also
possible that Tbx20 directly activates N-myc gene expression
since Tbx20 can have activator or repressor function depending
on transcriptional partners or cellular context (Plageman and
Yutzey, 2004; Stennard et al., 2003). The relevance of N-myc to
normal heart development was demonstrated directly by
targeted mutagenesis in mice. Mutant mice lacking N-myc
have complex cardiac abnormalities including a lack of
endocardial cushions, atrial and ventricular septal defects and
hypoplasia of the compact myocardium (Charron et al., 1992;
Hurlin, 2005; Moens et al., 1993). Extensive cell culture studies
have demonstrated that N-myc promotes cell cycle progression
at the G1/S-phase, and studies of Tbx5 in Xenopus embryos
support a role for this T-box family member in the G1 to S-
phase transition in cardiac myocytes (Goetz et al., 2006; Hooker
and Hurlin, 2006). In addition, TBX2 and TBX3 expression is
increased and promotes proliferation in a subset of mammary
Fig. 6. Tbx20 promotes endocardial cushion cell proliferation. Primary endocardial cushion cells were infected with adenoviruses expressing β-gal (Adβ-gal) or
Tbx20 (AdTbx20) for gain of function or transfected with Tbx20-specific or scrambled control siRNA for loss of function. Proliferation was measured using
immunohistochemistry for BrdU incorporation. Cells infected with AdTbx20 (B) exhibit increased BrdU incorporation (arrows indicate positively stained cells)
relative to cells infected with Adβ-gal (A). Cells transfected with Tbx20-specific siRNA (D) are less proliferative than cells transfected with scrambled siRNA (C). The
percent of BrdU-positive cells relative to total nuclei in each group is quantified (E). The asterisk represents a statistically significant difference compared to the Adβ-
gal control group while the cross represents a statistically significant difference compared to the no siRNA control group (n=3, P<0.01). Error bars represent standard
error of the mean.
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Fan et al., 2004; Prince et al., 2004; Vance et al., 2005). The
ability of Tbx20 to promote N-myc expression in the developing
heart may be indicative of an important role in regulation of cell
cycle progression at the G1/S-phase in both myocardial and
endocardial cushion cell populations.
Bmp2 is expressed in the myocardium of the AV canal and
is required for the initial stages of endocardial cushion
formation (Ma et al., 2005; Rivera-Feliciano and Tabin,
2006; Yamada et al., 2000). In this study, we report BMP2
induces Tbx20 in endocardial cushion cells and that loss of
Tbx20 function in cushion cells results in increased Tbx2
expression. In murine atrial and ventricular chamber myocar-
dium, Tbx20 represses Tbx2 expression, thereby allowing
chamber-specific differentiation and myocardial proliferationto occur (Cai et al., 2005; Singh et al., 2005; Stennard et al.,
2005). A similar regulatory relationship may occur during
endocardial cushion maturation. BMP2 can induce expression
of both Tbx20 and Tbx2 in the primary heart field and AV
canal (Plageman and Yutzey, 2004; Rivera-Feliciano and
Tabin, 2006; Yamada et al., 2000). In addition, Tbx20 may
exert positive feedback on Bmp2 expression (Cai et al., 2005),
although decreased Tbx20 expression has also been observed
to result in ectopic Bmp2 expression, suggesting that Tbx20
can negatively feedback on Bmp2 (Singh et al., 2005). In light
of all of these studies, the mechanism that regulates the precise
coordination of Bmp2, Tbx20 and Tbx2 expression still remains
unclear. In addition, future experiments are needed to assess
independent functions of Tbx20 and Tbx2 in chamber
myocardium and endocardial cushions.
Fig. 7. BMP2 induces Tbx20 and Tbx20 regulates the expression of Tbx2 and
N-myc in endocardial cushion cells. Endocardial cushion cells were cultured
with or without the addition of soluble recombinant BMP2 or Noggin, a BMP
inhibitor. Addition of BMP2 resulted in increased Tbx20 expression relative to
untreated controls, while addition of Noggin attenuated that response (A), as
measured by real-time RT-PCR. The expression of Tbx2 and N-myc, genes
associated with Tbx20-regulated proliferation, was measured in siRNA
transfected endocardial cushion cells using real-time RT-PCR. In cells
transfected with Tbx20-specific siRNA, Tbx2 expression is increased (B)
while N-myc expression is decreased relative to untransfected or scrambled
siRNA controls (C). Asterisks indicate statistically significant differences from
control values and error bars represent standard error of the mean (n=5,
P<0.01).
Fig. 8. Model for Tbx20 function in endocardial cushions and remodeling
valves. Endocardial cushions are characterized by highly proliferative
mesenchymal cells and unorganized extracellular matrix, while remodeling
valves are characterized by less proliferative interstitial cells and organized
extracellular matrix. These molecular and cellular characteristics are consistent
with a model in which high levels of Tbx20 in endocardial cushions induce
proliferation while maintaining an unremodeled, unorganized extracellular
matrix. In contrast, lower levels of Tbx20 in remodeling valves allow for a less
proliferative cell population and a more remodeled and organized extracellular
matrix.
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CSPGs and increased expression of MMPs in endocardial
cushion cells. This is consistent with a role for Tbx20 in ECM
remodeling during valve development. While altered Tbx20
function affects the expression of ECM remodeling genes, it is
not known whether these interactions are direct or indirect. In
previous studies a limited number of direct downstream targets
of Tbx20 have been identified, including Nppa and Tbx2 (Cai
et al., 2005; Stennard et al., 2003; Takeuchi et al., 2005). To
determine if Tbx20 interacts directly or indirectly with CSPG
and MMP regulatory elements, promoter regions of murine Aggand Mmp13 were analyzed for T-box binding sites (TBE).
While several conserved TBE sites were found in addition to
binding sites for common T-box co-factors, Tbx20 alone was
not sufficient to induce Agg or Mmp13 reporter constructs and
induction was not observed in co-transfection experiments (data
not shown). However, these studies do not rule out the
possibility that Tbx20 directly regulates CSPG and MMP
gene expression through other regulatory elements or with
additional co-factors. Direct transcriptional regulators of Agg
and Mmp13 have been identified in other cell types. Sox9 and
Scleraxis can directly activate Agg expression in chondrocytic
and osteoblastic cell lines respectively (Liu et al., 1997; Sekiya
et al., 2000), while Tgf-β and core-binding factor 1 (CBFA1)
can directly activate Mmp13 expression in human fibroblasts
and chondrocytic and osteoblastic cell lines (Jimenez et al.,
1999; Sternlicht andWerb, 2001; Uria et al., 1998). It is possible
that the effect of Tbx20 on CSPG and MMP expression is
indirect through the expression of genes such as Sox9, scler-
axis, Tgf-β or CBFA1, which are also present in endocardial
cushions and valve primordia (Lincoln et al., 2006a; Yutzey,
unpublished). With the data currently available, the effect of
Tbx20 as a direct or indirect transcriptional regulator of CSPG
or MMP gene expression cannot be determined.
In general, the ECM is important for many cellular processes
including cell shape, movement, growth, differentiation and
survival. Similarly, MMPs that degrade and remodel ECM
components can also affect all of these processes by altering the
structure and composition of the ECM (Sternlicht and Werb,
2001). During angiogenesis and bone development, MMPs
function to create a permissive environment for cell migration
(Sternlicht and Werb, 2001). Therefore, the expression of
MMPs in endocardial cushions composed of a loosely arranged
387E.L. Shelton, K.E. Yutzey / Developmental Biology 302 (2007) 376–388ECM is consistent with migratory, proliferative, mesenchymal
cells. The observed decrease in mmp9 and mmp13 expression
in remodeling valves may be required for organization of the
ECM and compartmentalization of interstitial cells (Hinton et
al., 2006). Correct expression and assembly of CSPGs is also
necessary for normal valve development. Transgenic mice
containing an insertional mutation in the versican gene fail to
form endocardial cushions (Kern et al., 2006; Mjaatvedt et al.,
1998) and proteoglycans are integral components of the mature
valve leaflet (Hinton et al., 2006). In this report, the observed
differential expression of CSPGs and MMPs during endocardial
cushion development and valve remodeling stages highlights
the importance of establishing a balance between deposition and
degradation of ECM components in order for normal valve
development to occur.
Human heart valve disease is associated with abnormal
organization and increased deposition of ECM constituents. In
a recent study of pediatric aortic valve disease, ECM layers
were unorganized and disproportionate and interstitial cell
compartmentalization was abnormal (Hinton et al., 2006).
Similarly, patients with congenital polyvalvular disease had
AV and semilunar valves composed of abnormal ECM and
disrupted valve architecture (Bartram et al., 2001). Further-
more, in cases of myxomatous and calcified adult aortic
valves, disorganized ECM was accompanied by elevated
levels of MMPs including MMP9 and MMP13 (Akhtar et al.,
1999; Bailey et al., 2004; Rabkin et al., 2001; Soini et al.,
2001). These features of valve disease, including unorganized
ECM and interstitial cells with elevated MMP levels, are all
characteristic of endocardial cushions. While features char-
acteristic of valve disease have been described, relatively little
is known about the molecular causes of valve pathogenesis.
As shown in this study, altered Tbx20 function affects valve
progenitor cell proliferation as well as expression of ECM
components and remodeling enzymes in AV valve precursor
cells. Therefore, it is possible that misregulation of Tbx20
could lead to some of the characteristic features of valve
disease. Further experiments examining the expression of
Tbx20 in diseased valves may give insights into molecular
mechanisms of valve disease.
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